Advances in Cirrhosis, Hyperammonemia, and Hepatic Encephalopathy, Softcover reprint of the original 1st ed. 1997 Advances in Experimental Medicine and Biology Series, Vol. 420

Proceedings of an international symposiu, held in Valencia, Spain, December 2-4, 1996

Brain Tryptophan Perturbation in Hepatic Encephalopathy: Implications for Effects by Neuropsychoactive Drugs in Clinical Practice.- Hepatic Encephalopathy in Acute Liver Failure: Role of the Glutamate System.- Glutamate and Muscarinic Receptors in the Molecular Mechanisms of Acute Ammonia Toxicity and of Its Prevention.- Studies on the Pharmacological Properties of Oxindole (2-Hydroxyindole) and 5-Hydroxyindole: Are They Involved in Hepatic Encephalopathy?.- The Involvement of Ammonia with the Mechanism that Enhance GABA-ergic Neurotransmission in Hepatic Failure.- Direct Enhancement of GABA-ergic Neurotransmission by Ammonia.- The Peripheral Benzodiazepine Receptor and Neurosteroids in Hepatic Encephalopathy.- Ornithine Aminotransferase as a Therapeutic Target in Hyperammonemias.- Sparse-Fur (spf) Mouse as a Model of Hyperammonemia: Alterations in the Neurotransmitter Systems.- Abnormal Gene Expression Causing Hyperammonemia in Carnitine-Deficient Juvenile Visceral Steatosis (JVS) Mice.- Hyperammonemia without Portal Systemic Shunting Does Not Resemble Hepatic Encephalopathy.- Magnetic Resonance Spectroscopy in the Study of Hyperammonemia and Hepatic Encephalopathy.- Osmosignalling and Osmolytes in Liver and Astrocytes.- Effects of Acid-Base Alterations and Protein Depletion on Hepatic Nitrogen Metabolism.- Glucose and Insulin Metabolism in Cirrhosis.- An Ammonia Hypothesis of Alzheimer Disease.- Living Related Liver Transplantation.- Contributors.